Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (15 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← Shortage register

Notification update · MSN/2025/062

Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches – updated

MSN/2025/062 Tier 3 · high · issued 03 Dec 2025

Reference
MSN/2025/062
Kind
Notification update
Issued
03 Dec 2025
Expected back
w/c late September 2026 as stated by the source — kept fuzzy
Recorded changes
5
Source
Announcement post ↗

Presentations, as stated

Each product line re-expressed as the product named, the status the source stated and its expected-back phrase kept as written — not the source's sentence, and not an observation of stock. Roles are inferred from phrasing.

PresentationStatus, as statedExpected back, as statedStated in
Alzest transdermal patches (Dr Reddy’s Laboratories (UK) Ltd) in all strengthsaffected product · inferred from phrasingDiscontinued, as stated— not stated for this lineupdate of 08 Jan 2026
Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patchesaffected product · inferred from phrasingLimited supply, as statedw/c late September 2026precision: a stated week · window end 06 Oct 2026, derived from “w/c late September 2026”notice of 03 Dec 2025
Rivastigmine 13.3mg/24hours transdermal patchesnamed by the source as remaining available · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 03 Dec 2025
Rivastigmine (Zeyzelf) twice weekly 4.6 mg/24hours transdermal patchnamed by the source as remaining available · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 03 Dec 2025
Rivastigmine (Zeyzelf) twice weekly 9.5 mg/24hours transdermal patchnamed by the source as remaining available · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 03 Dec 2025
Unlicensed supplies of rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patchesunlicensed import named by the source · inferred from phrasingStated as available— not stated for this linenotice of 03 Dec 2025
Alternative formulations of acetylcholinesterase (AChE) inhibitorsclass-level statement by the source, not a named product · inferred from phrasingStated as available⚠ the source line states more than one status — first stated shown— not stated for this linenotice of 03 Dec 2025

What changed

  1. 03 Dec 2025Supply notification issuedsource post
  2. 03 Dec 2025Expected backsource post
  3. 08 Jan 2026Notification updatedsource post
  4. 08 Jan 2026Product discontinuedsource post
  5. 04 Jun 2026Notification updatedsource post

Provenance

Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.

post:9738bdd4f9a4

Recorded
10 Jul 2026 16:47 UTC
Capture route
Captured first-hand by ShortageSignal's scheduled check
Read from
Community Pharmacy England post (DHSC notification as relayed)
Captured at
10 Jul 2026 16:47 UTC
Content hash
60d67ddab905ea036eaaffcd73afdb956e74625a86c0ba559a855b9ad1df8497
sha256 of the captured bytes — proves what was captured, not that the source was correct
Source document
https://cpe.org.uk/our-news/medicine-supply-notification-rivastigmine-4-6mg-24hours-and-9-5mg-24hours-transdermal-patches/ ↗
Parser version
3
Source anomalies
  • multiple statuses on one line (['available_no_uplift', 'available']) — recorded 'available_no_uplift' (source line omitted; see the source document)
  • multiple statuses on one line (['available_no_uplift', 'available']) — recorded 'available_no_uplift' (source line omitted; see the source document)
  • multiple statuses on one line (['available_no_uplift', 'available']) — recorded 'available_no_uplift' (source line omitted; see the source document)
  • multiple statuses on one line (['limited_supply', 'available']) — recorded 'limited_supply' (source line omitted; see the source document)
as recorded by the parser about the source as captured — flagged, never corrected
Subscribe to changes feed · calendar · site RSS · email
  • Atom Feed for RivastigminePaste this address into a feed reader (Outlook, Thunderbird, Feedly…): https://shortagesignal.co.uk/medicine/rivastigmine/feed.xml
  • Calendar Stated expected-back windows for RivastigmineAdd it to your calendar app as a subscription by URL and paste https://shortagesignal.co.uk/medicine/rivastigmine/expected.ics. Per the vendors' own help pages: Outlook on the web— Calendar → Add calendar → Subscribe from web (Microsoft says a subscribed calendar “can sometimes take more than 24 hours” to refresh); Google Calendar— Other calendars → Add other calendars → From URL. Refresh timing is the calendar app's, not ours.
  • RSS The newest 50 recorded changes, site-wide · weekly digest (feed)
  • Email Email alerts are not yet sending.Leave your address and we'll send a confirmation link when alerts launch — nothing is sent until then, and nothing after unless you click it.

Feeds and calendars follow our twice-daily scheduled checks of the sources — they are not live. See privacy for what a sign-up stores.

Dates are as stated in the source documents. Fuzzy source dates are kept fuzzy. Not an official NHS or DHSC service — in a shortage, follow the guidance issued to your pharmacy or prescriber.